Skip to main content
. 2021 Jun 2;47:126. doi: 10.1186/s13052-021-01075-8

Table 1.

Clinical and genetic characteristics of the series of 13 Serbian APECED patients including two novel case reports

Patient Sex/age at referral (years) Age of first symptom (years) AIRE mutation Major clinical manifestations related to APECEDe Other clinical manifestationse Reference
a, d1. M/3.5 3.5

c.769C > T

R257X (p.Arg257X)

Addison’s disease (3.5)

Hypoparathyroidism (4)

Present report
a, d2. F/4 4

c.769C > T

R257X (p.Arg257X)

Mucocutaneous candidiasis

Hypoparathyroidism (4)

Addison’s disease (11)

Ectodermal dystrophy

Diffuse alopecia with madarosis

Onychomycosis

Hashimoto’s thyroiditis (13.5)

POF (16)

Present report
a, c, d3. F/33 7

c.769C > T

R257X (p.Arg257X)

Hypoparathyroidism (7)

Addison’s disease (14)

Mucocutaneous candidiasis (16)

Pure red cell aplasia

Hashimoto’s thyroiditis

POF (30)

Renal dysfunction

Exocrine pancreas insufficiency (36)

[15]
4.(younger sister of patient 3) F

c.769C > T

R257X (p.Arg257X)

Chronic mucocutaneous candidiasis

Hypoparathyroidism

Addison’s disease

Pernicious anemia

Lichen ruber planus

[15]
a, d5.

c.769C > T

R257X (p.Arg257X)

Mucocutaneous candidiasis

Addison’s disease

Vitiligo

Alopecia

Ectodermal dystrophy

Autoimmune hepatitis

[16]
6. F/21 7.5

p.Glu298Lys/

p.Arg257X

c.892G > A/

c.769C > T

Hypoparathyroidism (7.5)

Addison’s disease (8)

Mucocutaneous candidiasis (11)

Autoimmune bronchiolitis (3.5)

Hypogonadism (12)

Chronic Otitis media with effusion (16.5)

Systemic Juvenile Rheumatoid Arthritis

Pernicious anemia (17)

[17]
a, b, c7. M/12 2

p. (=)/

p.Arg257X

c.462A > T/

c.769C > T

Addison’s disease (11)

Ectodermal dystrophy (2)

Malabsorption (2)

Vitiligo (2)

Alopecia (2.5)

[17]
8. F/8 1

c.769C > T

R257X (p.Arg257X)

Mucocutaneous candidiasis (1)

Addison’s disease (4)

Hypoparathyroidism (5)

Vitiligo (1) [17]
a, c, d9. F/22 5

c.769C > T

R257X (p.Arg257X)

Mucocutaneous candidiasis (5)

Addison’s disease (16)

Hypoparathyroidism (15)

Chronic hepatitis (15)

Pernicious anemia (16)

[17]
a, b, c10. M/20 6

c.769C > T

R257X

(p. Arg257X)

Mucocutaneous candidiasis (6)

Hypoparathyroidism (9)

Addison’s disease (11)

Malabsorption (9) [17]
a, c11. F/23 9

c.769C > T

R257X (p.Arg257X)

Hypoparathyroidism (9)

Mucocutaneous candidiasis (10)

Addison’s disease (10)

Alopecia (10)

Hypogonadism (18)

[17]
a, b, c12. M/19 10

c.769C > T

R257X (p.Arg257X)

Mucocutaneous candidiasis (11)

Hypoparathyroidism (13)

Addison’s disease (14)

Pernicious anemia (10)

Malabsorption (11)

Alopecia (13)

[17]
a, c13. F/20 15 not available

Adrenal insufficiency (15)

Hypoparathyroidism (15)

Graves’ disease (15)

Vitiligo (15)

POF (15)

Alopecia universalis (18)

Vogt-Koyanagi-Harada syndrome (20)

[18]

aAPECED patients for which sufficient information is retrospectively available to support a clinical diagnosis also based on the presence of Ferre/Lionakis criteria (i.e., presence of one symptom of the classic triad and one symptom of the adjunct triad of urticarial eruption, intestinal dysfunction and enamel hypoplasia). N = 10

bPatients for which sufficient information is retrospectively available and it was possible to confirm an earlier diagnosis based on Ferre/Lionakis criteria versus classic criteria. N = 3

cPatients for which sufficient information is retrospectively available to verify whether an earlier diagnosis based on Ferre/Lionakis criteria versus classic criteria was possible. N = 7

dIncompletely evaluable patients for an earlier diagnosis based on Ferre/Lionakis criteria versus classic criteria due to lack of information on the age of appearance of symptoms. N = 5

eAge of appearance of symptom (years)